Agenus to present at the 2021 asco annual meeting

Lexington, mass., april 28, 2021 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that it will give two presentations at the 2021 american society for clinical oncology (asco) annual meeting poster sessions. the asco meeting will be held from june 4 – 8, 2021.
AGEN Ratings Summary
AGEN Quant Ranking